Keyphrases
Cellular Immunity
100%
Humoral Immunity
100%
In Vivo Model
100%
Multivalent
100%
Enterohemorrhagic Escherichia Coli
100%
Gold Nanoparticles
100%
Nanoparticle Vaccine
100%
Preventive Vaccine
16%
Cellular Response
16%
Economic Impact
16%
Mechanistic Studies
16%
Broad Protection
16%
Prophylactic Vaccine
16%
Human Use
16%
Intestinal Epithelial Cells
16%
Antigen-specific
16%
Nanotechnology
16%
Vaccine Formulation
16%
Antibiotic Use
16%
Humoral Response
16%
Antibody-mediated Protection
16%
Disease-specific Mortality
16%
Escherichia Coli Vaccines
16%
Escc
16%
Macrophage Killing
16%
Gold Nanoparticles(AuNPs)
16%
Au Nanoparticles (AuNPs)
16%
Bacterial Adherence
16%
Macrophage Uptake
16%
Platform-Based
16%
Reverse Vaccinology
16%
Immunogenic Antigens
16%
Disease Sequelae
16%
Product Recall
16%
Medicine and Dentistry
Cellular Immunity
100%
Humoral Immunity
100%
Escherichia Coli O157
100%
Enterohemorrhagic Escherichia Coli
100%
Gold Nanoparticle
100%
Pathogen
50%
In Vitro
16%
Infection
16%
Sequela
16%
Prevalence
16%
Antigen Specificity
16%
Macrophage
16%
Epithelial Cell
16%
Contraindication
16%
Bacterium Adherence
16%
Disease Carrier
16%
Escherichia Coli Vaccine
16%
Immunology and Microbiology
Humoral Immunity
100%
Adoptive Immunity
100%
Escherichia Coli O157:H7
100%
Enterohemorrhagic Escherichia Coli
100%
Immunology
66%
Infectious Agent
50%
Macrophage
16%
Antigen Specificity
16%
Prevalence
16%
Escherichia Coli Vaccine
16%
Bacterium Adherence
16%
Reverse Vaccinology
16%
Biochemistry, Genetics and Molecular Biology
Humoral Immunity
100%
Cellular Immunity
100%
Enterohemorrhagic Escherichia Coli
100%
Escherichia Coli O157
100%
Infectious Agent
50%
Macrophage
16%
Prevalence
16%
Antigen Specificity
16%
Bacterium Adherence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Escherichia Coli O157
100%
Gold Nanoparticle
100%
Enterohemorrhagic Escherichia Coli
100%
Infectious Agent
50%
Infection
16%
Prevalence
16%
Gold Nanoparticle
16%
Escherichia Coli Vaccine
16%
Disease Carrier
16%